ReviewHematology. American Society of Hematology. Education Program2025
The role of MRD monitoring and options for CLL management in relapsed/refractory disease.
Brian Sworder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewHematology. American Society of Hematology. Education Program2025
Brian Sworder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.